Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit

Journal of Molecular Biology

Volumn 330, Issue 5, 2003, Pages 1061-1075

  Hansen, Jeffrey L ^a   Moore, Peter B ^a,b   Steitz, Thomas A ^a,b,c  

^a Dept of Molec Biophys/Biochem ^*  (United States)

^b YALE UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Anisomycin; Blasticidin; Chloramphenicol; Peptidyl transferase center; Virginiamycin

Indexed keywords

ANISOMYCIN; ANTIBIOTIC AGENT; BLASTICIDIN S; CHLORAMPHENICOL; METAL ION; PEPTIDYLTRANSFERASE; SPARSOMYCIN; VIRGINIAMYCIN M;

ARTICLE; CHIRALITY; COMPETITIVE INHIBITION; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME CONFORMATION; HALOARCULA MARISMORTUI; HYDROGEN BOND; HYDROPHOBICITY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RIBOSOME SUBUNIT; X RAY CRYSTALLOGRAPHY;

ESCHERICHIA COLI; HALOARCULA; HALOARCULA MARISMORTUI;

EID: 0038013670     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00668-5     Document Type: Article

References (89)

1. Ban N., Nissen P., Hansen J., Moore P., Steitz T. The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science. 289:2000;905-920.
2. Wimberly B.T., Brodersen D.E., Clemons W.M., Morgan-Warren R.J., Carter A.P., Vonrhein C., et al. Structure of the 30 S ribosomal subunit. Nature. 407:2000;327-339.
3. Schluenzen F., Tocilj A., Zarivach R., Harms J., Gluehmann M., Janell D., et al. Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. Cell. 102:2000;615-623.
4. Pioletti M., Schlunzen F., Harms J., Zarivach R., Gluhmann M., Avila H., et al. Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J. 20:2001;1829-1839.
5. Carter A.P., Clemons W.M.J., Brodersen D.E., Morgan-Warren R.J., Wimberly B.T., Ramakrishnan V. Functional insights from the structure of the 30 S ribosomal subunit and its interactions with antibiotics. Nature. 407:2000;306-307.
6. Brodersen D.E., Clemons W.M., Carter A.P., Morgan-Warren R.J., Wimberly B.T., Ramakrishnan V. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30 S ribosomal subunit. Cell. 103:2000;1143-1154.
7. Hansen J., Ippolito J., Ban N., Nissen P., Moore P., Steitz T. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell. 10:2002;117-128.
8. Schlunzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 413:2001;814-821.
9. Hofs H.P., Wagener D.J., de Valk-Bakker V., van Rennes H., de Vos D., Doesburg W.H., et al. Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agents. Anticancer Drugs. 6:1995;277-284.
10. Dubois R.J., Lin C.C., Michel B.L. Synthesis of sparsomycin analogs as potential antitumor agents. J. Pharm. Sci. 64:1975;825-829.
11. Lam R.F., Lai J.S., Ng J.S., Rao S.K., Law R.W., Lam D.S. Topical chloramphenicol for eye infections. Hong Kong Med. J. 8:2002;44-47.
12. Kimura M., Yamaguchi I. Recent development in the use of blasticidin S, a microbial fungicide as a useful reagent in molecular biology. Pest. Biochem. Phys. 56:1996;243-248.
13. Johnston J.J., Mukhtar T.A., Wright G.D. Streptogramin antibiotics: mode of action and resistance. Cur. Drug Targets. 3:2000;335-344.
14. Contreras A., Vazquez D. Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes. Eur. J. Biochem. 74:1977;539-547.
15. Yarmolinsky M.B., de la Haba G.L. Inhibition by puromycin of amino acid incorporation into protein. Proc. Natl Acad. Sci. USA. 45:1959;1721-1729.
16. Allen D.W., Zamecnik P.C. The effect of puromycin on rabbit reticulocyte ribosomes. Biochim. Biophys. Acta. 55:1962;865-874.
17. Jardetzky O. Studies on the mechanism of action of chloramphenicol. J. Biol. Chem. 238:1963;2498-2508.
18. Coutsogeorgopoulos C. On the mechanism of action of chloramphenicol in protein synthesis. Biochim. Biophys. Acta. 129:1966;214-217.
19. Kirillov S., Porse B.T., Vester B., Woolley P., Garrett R.A. Movement of the 3′-end of tRNA throuugh the peptidyl transferase centre and its inhibition by antibiotics. FEBS Letters. 406:1997;223-233.
20. Vester B., Garrett R.A. The importance of highly conserved nucleotides in the binding region of chloramphenicol at the peptidyl transferase centre of Escherichia coli 23 S ribosomal RNA. EMBO J. 7:1988;3577-3587.
21. Coutsogeorgopoulos C. Amino acylaminonucleoside inhibitors of protein synthesis. The effects of amino acyl ribonucleic acid on the inhibition. Biochemistry. 6:1967;1704-1711.
22. Ballesta J.P.G., Lazaro E. Peptidyltransferase inhibitors: structure-activity relationship analysis by chemical modification. Hill W.E., Dahlberg A., Garrett R.A., Moore P.B., Schlessinger D., Warner J.R. The Ribosome: Structure, Function, and Evolution. 1990;502-510 American Society for Microbiology, Washington, DC.
23. Nissen P., Hansen J., Ban N., Moore P., Steitz T. The structural basis of ribosome activity in peptide bond synthesis. Science. 289:2000;920-930.
24. Brunger A.T., Adams P., Glore G.M., Delano W.L., Gros P., Grosse-Kunstlev R.W., et al. Crystallography and NMR System (CNS): a new software system for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
25. Schmeing T.M., Seila A.C., Hansen J.L., Freeborn B., Soukup J.K., Scaringe S.A., et al. A pre-translocation intermediate in protein synthesis observed in crystals of enzymatically active 50 S subunits. Nature Struct. Biol. 9:2002;225-230.
26. Cannone J.J., Subramanian S., Schnare M.N., Collett J.R., D'Souza L.M., Du Y., et al. The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal intron, and other RNA's. BMC Bioinformat. 3:2002;2-31.
27. Hansen J.L., Schmeing T.M., Moore P.B., Steitz T.A. Structural insights into peptide bond formation. Proc. Natl Acad. Sci. USA. 99:2002;11670-11765.
28. 3H)anisomycin binding to eukaryotic ribosomes. J. Mol. Biol. 84:1974;603-623.
29. Gale E.F., Cundliffe E., Reynolds P.E., Richmond M.H., Waring M.J. The Molecular Basis of Antibiotic Action. 1981;Wiley, London.
30. Klein D.J., Schmeing T.M., Moore P.B., Steitz T.A. The kink-turn; a new RNA motif. EMBO J. 20:2001;4214-4221.
31. Hummel H., Bock A. 23 S ribosomal RNA mutations in halobacteria conferring resistance to the anti-80 S ribosome targeted antibiotic anisomycin. Nucl. Acids Res. 15:1987;2431-2443.
32. Rodriguez-Fonseca C., Amils R., Garrett R.A. Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibioticribosome complexes. J. Mol. Biol. 247:1995;224-235.
33. Schaefer J.P., Wheatley P.J. Structure of anisomycin. J. Org. Chem. 33:1968;166-169.
34. Eguchi Y., Iitaka Y. The β-form of chloramphenicol palmitate. Acta Crystallog. sect. B. 30:1974;2781-2783.
35. Ravindra B.K., Sake Gowda D.S. The structure of chloramphenicol. Acta Crystallog. sect. B. 35:1978;1350-1363.
36. Ettayebi M.S., Prasad S.M., Morgan E.A. Chloramphenicol-erythromycin resistance mutations in a 23 S rRNA gene of Escherichia coli. J. Bacteriol. 162:1985;551-557.
37. Monro R.E., Celma M.L., Vazques D. Action of sparsomycin on ribosome-catalyzed peptidyl transfer. Nature. 222:1969;356-358.
38. Moazed D., Noller H.F. Sites of interaction of the -CCA end of peptidyltRNA with 23 S rRNA. Proc. Natl Acad. Sci. USA. 88:1991;3725-3728.
39. Jayaraman J., Goldberg I.H. Localization of sparsomycin action to the peptide-bond-forming step. Biochemistry. 7:1968;418-421.
40. Porse B.T., Kirillov S.V., Awayez M.J., Ottenheijm H.C.J., Garrett R.A. Direct crosslinking of the antitumor antibiotic spasomycin, and its derivatives, to A2602 in the peptidyl transferase center of 23 S-like rRNA within ribosome-tRNA complexes. Proc. Natl Acad. Sci. USA. 96:1999;9003-9008.
41. Lazaro E., Van den Broek L.A., San Felix A., Ottenheijm H.C., Ballesta J.P. Chemical, biochemical and genetic endeavours characterizing the interaction of sparsomycin with the ribosome. Biochimie. 73:1991;1137-1143.
42. van den Broek L.A., Liskamp R.M., Colstee J.H., Lelieveld P., Remacha M., Vazquez D., et al. Structure-activity relationships of sparsomycin and its analogues: inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth. J. Med. Chem. 30:1987;325-333.
43. Pestka S. Studies on the formation of transfer ribonucleic acid-ribosome complexes. XI. Antibiotic effects on phenylalanyl-oligonucleotide binding to ribosomes. Proc. Natl Acad. Sci. USA. 64:1969;709-714.
44. Lazaro E., van den Broek L.A., San Felix A., Ottenheijm H.C., Ballesta J.P. Biochemical and kinetic characteristics of the interaction of the antitumor antibiotic sparsomycin with prokaryotic and eukaryotic ribosomes. Biochemistry. 30:1991;9642-9648.
45. Chinali G., Moureau P., Cocito C.G. The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase. J. Biol. Chem. 259:1984;9563-9568.
46. Vazques D. The streptogramin family of antibiotics. Gottlieb D., Shaw P.D. Antibiotics I. Mechanism of Action. 1967;387-403 Springer-Verlag, New York.
47. Parfait R., Cocito C. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M. Proc. Natl Acad. Sci. USA. 77:1980;5492-5496.
48. Cundliffe E. Recognition sites for antibiotics within rRNA. Hill W.E., Dahlberg A., Garrett R.A., Moore P., Schlessinger D., Warner J.R. The Ribosome: Structure, Function, and Evolution. 1990;479-490 American Society for Microbiology, Wahington, DC.
49. Durant F., Evrard G., Declercq J.P., Germain G. Virginiamycin: factor M-dioxane. Cryst. Struct. Commun. 3:1974;503-510.
50. Sugantino M., Roderick S.L. Crystal structure of Vat (D): an acetyltransferase that inactivates streptogramin group A antibiotics. Biochemistry. 41:2002;2209-2216.
51. Samaha R.R., Green R., Noller H.F. A base-pair between tRNA and 23 S rRNA in the peptidyl transferase centre of the ribosome. Nature. 377:1995;309-314.
52. Suhadolnik R.J. Nucleoside Antibiotics. 1970;Wiley, New York.
53. Lichtenthaler F.W., Trummlitz G. Structural basis for inhibition of protein synthesis by the aminoacyl-aminohexosyl-cytosine group of antibiotics. FEBS Letters. 38:1974;237-242.
54. Porse B., Rodriguez-Fonseca C., Leviev I., Garrett R.A. Antibiotic inhibition of the movement of tRNA substrates through a peptidyl transferase cavity. Biochem. Cell Biol. 73:1995;877-885.
55. Moazed D., Noller H.F. Chloramphenicol, erythromycin, carbomycin, and vernamycin B protect overlapping sites in the peptidyl transferase region of 23 S ribosomal RNA. Biochimie. 69:1987;879-884.
56. Lovett P.S. Translation attenuation regulation of chloramphenicol reistance in bacteria - a review. Gene. 179:1996;157-162.
57. Fernandez-Munoz R., Monro R.E., Torres-Pinedo R., Vazquez D. Substrate and antibiotic-binding sites at the peptidyl-transferase-centre of Escherichia coli ribosomes. Eur. J. Biochem. 23:1971;185-193.
58. Nierhaus D., Neirhaus K.H. Identification of the chloramphenicol-binding protein in Escherichia coli ribosomes by partial reconstitution. Proc. Natl Acad. Sci. USA. 70:1973;2224-2228.
59. Wolfe A.D., Hahn F.E. Mode of action of chloramphenicol: IX. Effects of chloramphenicol upon a ribosomal amino acid polymerazation system and its binding to bacterial ribosome. Biochim. Biophys. Acta. 95:1965;146-155.
60. Lessard J.L., Pestka S. Studies on the formation of transfer ribonucleic acid-ribosome complexes. J. Biol. Chem. 247:1972;6909-6912.
61. Oleinick N.L., Wilhelm J.M., Corcoran J.W. Nonidentity of the site of action of erythromycin A and chloramphenicol on Bacillus subtilis ribosomes. Biochim. Biophys. Acta. 155:1967;290-292.
62. Drainas D., Kalpaxis D.L., Coutsogeorgopoulos C. Inhibition of ribosomal peptidyltransferase by chloramphenicol. Eur. J. Biochem. 164:1987;53-58.
63. Theocharis D.A., Synetos D., Kalpaxis D.L., Drainas D., Coutsogeorgopoulos C. Kinetics of inhibition of peptide bond formation on bacterial ribosomes. Arch. Biochem. Biophys. 292:1992;266-272.
64. Rheinberger H.J., Nierhaus K.H. Partial release of AcPhe-Phe-tRNA from ribosomes during poly(U)-dependent poly(Phe) synthesis and the effects of chloramphenicol. Eur. J. Biochem. 193:1990;643-650.
65. Mao J.C.H., Robishaw E.E. Effects of macrolides on peptide-bond formation and translocation. Biochemistry. 10:1971;2054-2061.
66. Poulsen S.M., Kofoed C., Vester B. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. J. Mol. Biol. 304:2000;471-481.
67. Yukioka M., Hatayama T., Morisawa S. Affinity labeling of the ribonucleic acid component adjacent to the peptidyl recognition center of peptidyl transferase in Escherichia coli ribosomes. Biochim. Biophys. Acta. 390:1975;192-208.
68. Grivell L.A., Netter P., Borst P., Slonimski P. Mitochondrial antibiotic resistance in yeast: ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin. Biochim. Biophys. Acta. 312:1973;358-367.
69. Vazques D. Antibiotics which affect protein synthesis: the uptake of 14Cchloramphenicol by bacteria. Biochem. Biophys. Res. Commun. 12:1963;409-413.
70. Vazques D. Binding of chloramphenicol to ribosomes the effect of a number of antibiotics. Biochim. Biophys. Acta. 114:1966;277-288.
71. Langlois R., Cantor C.R., Vince R., Pestka S. Interaction between erythromycin and chloramphenicol-binding sites on the Escherichia coli ribosome. Biochemistry. 16:1977;2349-2355.
72. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
73. Swaminathan V., Smith J.L., Sundaralingam M., Coutsogeorgopoulos C., Kartha G. Crystal and molecular structure of the antibiotic blasticidin S hydrochloride pentahydrate. Biochim. Biophys. Acta. 655:1981;335-341.
74. Shin W., Pyo M. The crystal and molecular structure of chloramphenicol base. Bull. Korean Chem. Soc. 5:1984;158.
75. Acharya K.R., Gourd D.S., Post M. The structure of chloramphenical. Acta Crystallog. sect. B. 35:1979;1360-1363.
76. Wiley P.F., MacKellar F.A. Sparsomycin, structure and chemistry. J. Org. Chem. 41:1976;1858-1862.
77. Ash R.J., Flynn G.A., Liskamp R.M., Ottenheijm H.C. Sulfoxide configuration in sparsomycin determines time-dependent and competitive inhibition of peptidyl transferase. Biochem. Biophys. Res. Commun. 125:1984;784-789.
78. Nakajima N., Enomoto T., Matsuura N., Ubukata M. Synthesis and morphological reversion activity on srctsNRK cells of pyrimidinylpropanamide antibiotics, sparsomycin, sparoxomycin A1, A2, and their analogues. Bioorg. Med. Chem. Letters. 8:1998;3331-3334.
79. Kleywegt G.J., Jones T.A. Model-building annd refinement practice. Methods Enzymol. 277:1997;208-230.
80. Parkinson G., Vojtechovsky J., Clowney L., Brunger A.T., Berman H.M. New parameters for the refinement of nucleic acid containing structures. Acta Crystallog. 5:1996;57-64.
81. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
82. Christopher J.A. SPOCK: the Structural Properties Observation and Calculation Kit (Program Manual). 1998;The Center for Macromolecular Design, Texas A & M University, College Station, TX.
83. Kearsey S.E., Craig I.W. Altered ribosomal RNA genes in mitochondria from mammalian cells with chloramphenicol resistance. Nature. 290:1981;607-608.
84. Blanc H., Wright C.T., Bibb M.J., Wallace D.C., Clayton D.A. Mitochondrial DNA of chloramphenicol-resistant mouse cells contains a single nucleotide change in the region encoding the 3′ end of the large ribosomal RNA. Proc. Natl Acad. Sci. USA. 78:1981;3789-3793.
85. Dujon B. Sequence of the intron and flanking exons of the mitochondrial 21 S rRNA gene of yeast strains having different alleles at the rib-1 loci. Cell. 20:1980;185-197.
86. Blanc H., Adams C.W., Wallace D.C. Different nucleotide changes in the large rRNA gene of the mitochondrial DNA confer chloramphenicol resistance on two human cell lines. Nucl. Acids Res. 9:1981;5785-5795.
87. Tan G.T., DeBlasio A., Mankin A.S. Mutations in the peptidyl transferase center of 23 S rRNA reveal the site of action of sparsomycin, a universal inhibitor of translation. J. Mol. Biol. 261:1996;222-230.
88. Lazaro E., Rodriguez-Fonseca C., Porse B., Urena D., Garrett R.A., Ballesta J.P.G. A sparsomycin-resistant mutant of Halobacterium salinarium lacks a modification at nucleotide U2603 in the peptidyl transferase centre of 23 S rRNA. J. Mol. Biol. 261:1996;231-238.
89. Porse B.T., Garrett R.A. Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23 S rRNA and the synergism of their inhibitory mechanisms. J. Mol. Biol. 286:1998;375-387.